VITASPRING BIOMEDICAL CO., LTD. Net Income (Loss) Available to Common Stockholders, Diluted
VITASPRING BIOMEDICAL CO., LTD. (VSBC) reported Net Income (Loss) Available to Common Stockholders, Diluted of $3.00 million for the 13-month period ending 2018-01-31, per its 10-K filed 2018-05-16.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2018-05-16
- 2018-01-31: Net Income (Loss) Available to Common Stockholders, Diluted 13 month $3.00M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 13 month |
|---|---|
| 2018-01-31 | $3.00M 10-K · filed 2018-05-16 |